SECsense Logo

Zura Bio Limited 8-K Report: Key Insights for Investors and Shareholders

$ZURA
Form 8-K
Filed on: 2025-01-13
Source
Zura Bio Limited 8-K Report: Key Insights for Investors and Shareholders

Based on the provided XML section of the financial report, here are the key insights:

  1. Entity Information:
  • Company Name: Zura Bio Limited
  • CIK: 0001855644
  • Ticker Symbol: ZURA
  • Exchange: NASDAQ
  • Address: 1489 W. Warm Springs Rd. #110, Henderson, NV 89014
  • Phone: 702-757-6133
  1. Filing Type:
  • Form Type: 8-K (a report of unscheduled material events or corporate changes)
  1. Filing Date:
  • Date of Filing: January 13, 2025
  1. Share Information:
  • Share Class: Class A Ordinary Shares
  • Par Value: $0.0001 per share
  1. Financial Context:
  • Reporting Period: As of January 13, 2025
  • Currency: USD
  • Units of Measurement: Shares and USD per share
  1. Regulatory Framework:
  • The filing is compliant with SEC regulations and follows the XBRL (eXtensible Business Reporting Language) format for financial reporting.

Insights:

  • Zura Bio Limited is publicly traded on the NASDAQ under the ticker ZURA, indicating its status as a publicly held company.
  • The 8-K filing suggests an important event or corporate development that may require disclosure to shareholders and regulatory bodies.
  • The par value of the shares is notably low, which is common for many tech and biotech firms aiming to maintain flexibility in their capital structure.

Overall, this section provides a snapshot of Zura Bio Limited's regulatory compliance and share structure as of January 2025. Further analysis of the 8-K filing itself would be needed to understand the specific events or changes being reported.